Gen Z Women Are Ditching The 'Girlboss' Lie For Tradwife Life, Putting Family First

GLP-1 Feud Ends: NOVO, HIMS Join Forces (Again) To Sell Obesity Drugs The epic, months-long GLP-1 feud between Novo Nordisk and telehealth firm Hims & Hers Health appears to be coming to a surprising end, with both companies reportedly set to announce, as soon as Monday, a new partnership that would allow the Danish drugmaker to sell Wegovy through HIMS' platform. Bloomberg published the report late Friday, stating: Novo Nordisk A/S plans to sell its weight-loss drugs on Hims & Hers Health Inc.'s platform, according to a person familiar with the matter... ... Novo...

A US submarine sank an Iranian warship with a torpedo in the Indian Ocean off the coast of Sri Lanka, marking an escalation and widening of the US-Israeli war against Iran. Secretary of War Pete Hegseth confirmed during a press briefing that the US sank the vessel. “Yesterday, in the Indian Ocean … an American […]

Wall Street Keeps Testing AI Traders, But Most Are Still Underperforming Recent trading competitions suggest large language models are still unreliable portfolio managers, according to Bloomberg. Tests involving models from OpenAI, Anthropic, Google, and xAI have often delivered underwhelming results: many lost money, traded excessively, and made erratic decisions despite receiving identical prompts. In several cases, models appeared unable to stick to coherent strategies for more than a few trading sessions. Bloomberg writes that one of the clearest examples came from Alpha Arena, a competition created by startup Nof1. Eight models were...